NDC 49884-900-98 - Nystatin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49884-900
- Requested NDC
- 49884-900-98
- Package NDCs from labels
- 49884-900-98, 49884-900-18
- Manufacturer
- Par Pharmaceutical Inc.
- Effective date
- 2007-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nystatin - Par Pharmaceutical Inc. | Par Pharmaceutical Inc. | 2007-08-10 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49884-900-18 | Nystatin | 15 g in 1 BOTTLE, PLASTIC | POWDER | 15 | 2 | |
| 49884-900-98 | Nystatin | 56.7 g in 1 BOTTLE, PLASTIC | POWDER | 56.7 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Nystatin | ACTIVE INGREDIENT | BDF1O1C72E | NYSTATIN (NYSTATIN) POWDER [PAR PHARMACEUTICAL INC.] | 2 | |
| Nystatin | ACTIVE MOIETY | BDF1O1C72E | NYSTATIN (NYSTATIN) POWDER [PAR PHARMACEUTICAL INC.] | 2 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | NYSTATIN (NYSTATIN) POWDER [PAR PHARMACEUTICAL INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystop | NYSTATIN | Bryant Ranch Prepack | 0bb31239-fb77-442a-a9ee-ba61b45e7e68 | 2026-07-14 | Adverse reactions | 646456 |
| KLAYESTA | NYSTATIN TOPICAL POWDER | Epic Pharma, LLC | 0df13b1e-0e07-4123-a83a-1d7afb56170f | 2025-12-17 | Adverse reactions | 646456 |
| Nystop | NYSTATIN | Bryant Ranch Prepack | 64041bdf-1207-47f6-93f3-bc4656a7d2ae | 2025-10-21 | Adverse reactions | 646456 |
| Nystop | NYSTATIN | Bryant Ranch Prepack | affea013-4f09-4e7d-a696-9f501d379af6 | 2025-10-21 | Adverse reactions | 646456 |
| Nystatin | NYSTATIN | Northstar Rx LLC | 9e6d0b0d-a68f-46aa-a707-3110ecb931b4 | 2025-09-30 | Adverse reactions | 646456 |
| Nystop | NYSTATIN | Bryant Ranch Prepack | 69ebb4dd-f45d-448d-97cd-3f8935493975 | 2025-08-26 | Adverse reactions | 646456 |
| Nyamyc | NYSTATIN | Upsher-Smith Laboratories, LLC | 01b44f91-9b68-464a-9693-b5d3e793bf3c | 2025-07-09 | Adverse reactions | 646456 |
| NYSTATIN | NYSTATIN | Zydus Lifesciences Limited | 5d593aa9-f2e4-4adf-9f02-37832ffcb5b4 | 2024-12-03 | 646456 | |
| Nystop | NYSTATIN | Padagis US LLC | e1b4622c-0f9f-4c00-b42c-2aa85a5e3d4f | 2024-10-31 | Adverse reactions | 646456 |
| NYSTATIN | NYSTATIN | Leading Pharma, LLC | 089e6444-2bd1-443e-acf0-dfeaa69faef9 | 2024-04-18 | 646456 | |
| Nystatin | NYSTATIN | Dr. Reddy's Labratories Inc. | 6bde84a1-341d-09ce-58b6-f9a653dc98c5 | 2024-04-12 | Adverse reactions | 646456 |
| Nystop | NYSTATIN | Bryant Ranch Prepack | 87175864-9877-4e80-b870-907abb8ac289 | 2024-03-22 | Adverse reactions | 646456 |
| Nystop | NYSTATIN | Bryant Ranch Prepack | 5bce98a3-2964-4edc-b8da-8a46dafadf5e | 2024-01-11 | Adverse reactions | 646456 |
| NYSTATIN | NYSTATIN | Zydus Pharmaceuticals USA Inc. | 2daf159d-6a12-4b5d-97b3-8069c17e7635 | 2023-11-04 | Adverse reactions | 646456 |
| Nystatin Topical Powder | NYSTATIN TOPICAL POWDER | Epic Pharma, LLC | fb2a480e-0bb1-445e-bbb6-701dea6dc631 | 2023-08-10 | Adverse reactions | 646456 |
| Nystatin Topical Powder | NYSTATIN TOPICAL POWDER | Epic Pharma, LLC | 7f313a3b-7a4c-47fb-ad9f-e267514db527 | 2018-05-02 | Adverse reactions | 646456 |
| 3763536D-794E-310E-E9F1-48F105BB9457 | e5d3d8e4-3a92-4ac0-8918-d3209a30c12b | 2007-08-10 | Adverse reactions | 3763536D-794E-310E-E9F1-48F105BB9457 e5d3d8e4-3a92-4ac0-8918-d3209a30c12b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.